H1B Report
Side-by-side comparison

Deloitte Consulting LLP vs Southern Oregon Hospitalists, PC

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
Deloitte Consulting LLP
PARank #4FEIN 06-1454513
Entity B
Southern Oregon Hospitalists, PC
ORRank #FEIN 20-2088973

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricDeloitte Consulting LLPSouthern Oregon Hospitalists, PC
Total filings80,81349
Certified %98.23%95.92%
Denied %1.09%2.04%
Withdrawn %0.61%2.04%
Cert-withdrawn %0.07%0.00%
Rank#4
Active yearsFY2010–FY2026FY2010–FY2026
Worksite statePAOR

Outcomes — Deloitte Consulting LLP

DOL case-status mix.

Outcome breakdown: Certified 98.2%, Cert-withdrawn 0.1%, Withdrawn 0.6%, Denied 1.1%
Outcome breakdown
OutcomeShare
Certified98.2%
Cert-withdrawn0.1%
Withdrawn0.6%
Denied1.1%
Certified98.2%
Cert-withdrawn0.1%
Withdrawn0.6%
Denied1.1%

Outcomes — Southern Oregon Hospitalists, PC

DOL case-status mix.

Outcome breakdown: Certified 95.9%, Withdrawn 2.0%, Denied 2.0%
Outcome breakdown
OutcomeShare
Certified95.9%
Withdrawn2.0%
Denied2.0%
Certified95.9%
Withdrawn2.0%
Denied2.0%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

Deloitte Consulting LLP
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20102,375
FY20113,610
FY20124,716
FY20136,082
FY20147,007
FY20157,572
FY20167,629
FY20177,147
FY201816,089
FY20197,754
FY202052
FY202135
FY202211
FY20231,134
FY20242,702
FY20254,286
FY20262,612
Southern Oregon Hospitalists, PC
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20101
FY20113
FY20122
FY20131
FY20142
FY20156
FY20165
FY20172
FY20188
FY20196
FY20200
FY20210
FY20220
FY20230
FY20242
FY20254
FY20267

Top 5 occupations — Deloitte Consulting LLP

Top 5 occupations — Southern Oregon Hospitalists, PC

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.